Title: Feasibility and use fullness of VIA-VILI in Gynae OPD for Extended Gynecologic Examination

Authors: Naik Meena MD MRCOG, Ratnani Rekha MD

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i7.172

Abstract

Cervical cancer is the leading cause of cancer related death in developing countries .India has 1/5th of global burden of cervical cancer .it is majorly due to lack of screening facilities in developing countries. VIA /VILI has been studied for population screening in various studies and found to have very high sensitivity for detection of cervical pre-invasive lesions .We studied the feasibility and usefulness of VIA /VILI as a part of routine extended gynaec examination in OPD setup for all women coming to gynae OPD and its role in detection of preinvasive and invasive cervical lesions. 

References

1.      Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Lyon: International Agency for Research on Cancer; 2010. [Last accessed on 2011 Nov 20]. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Available from: http://globocan.iarc.fr .

2.      Shastri SS, Dinshaw K, Amin G, Goswami S, Patil S, Chinoy R, et al. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ. 2005;83: 186–94. [PMC free article] [PubMed]

3.      Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian P, et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer. 2003;106:404–8. [PubMed]

4.      Bhatla N, Gulati A, Mathur SR, Rani S, Anand K, Muwonge R, et al. Evaluation of cervical screening in rural North India. Int J Gynaecol Obstet. 2009;105:145–9. [PubMed]

5.      Sankaranarayanan R, Nessa A, Esmy PO, Dangou JM. Visual inspection methods for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol. 2012;26:221–32. [PubMed]

6.      Ghosh P, Gandhi G, Kochhar PK, Zutshi V, Batra S. Visual inspection of cervix with Lugol´s iodine for early detection of premalignant and malignant lesions of cervix. Indian J Med Res. 2012;136:265–71.[PMC free article] [PubMed]

7.      Sankaranarayanan R, Basu P, Wesley R, Mahe C, Keita N, Mbalawa CC, et al. IARC Multicentre Study Group on Cervical Cancer Early Detection. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer. 2004;110:907–13. [PubMed]

8.      Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, Mbalawa CG, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer. 2008;123:153–60. [PubMed]

9.      Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360: 1385–94. [PubMed]

10.  Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: A cluster randomized trial. Lancet. 2007;370:398–406. [PubMed]

11.  Sankaranarayanan R, Rajkumar R, Esmy PO, Fayette JM, Shanthakumary S, Frappart L, et al. Effectiveness, safety and acceptability of ‘see and treat’ with cryotherapy by nurses in a cervical screening study in India. Br J Cancer. 2007;96:738–43. [PMC free article] [PubMed]

12.  Nene BM, Hiremath PS, Kane S, Fayette JM, Shastri SS, Sankaranarayanan R. Effectiveness, safety, and acceptability of cryotherapy by midwives for cervical intraepithelial neoplasia in Maharashtra, India. Int J Gynaecol Obstet. 2008;103:232–6. [PubMed]

13.  Alliance for Cervical Cancer Prevention. New evidence on the impact of cervical cancer screening and treatment using HPV DNA tests, visual inspection, or cytology. Cervical Cancer Prevention Fact Sheet. 2009

14.  Government of India and World Health Organization. Guidelines for cervical cancer screening program. Recomme-ndation of the Expert Group Meeting held on 18-19 Nov 2005. 2006

15.  [Last accessed on 2012 Mar 18]. Available form: http://www.cervicalcanceraction.org/comments/map-slideshow-via.php .

16.  Nessa A, Hussain MA, Rahman JN, Rashid MH, Muwonge R, Sankaranarayanan R. Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid. Int J Gynaecol Obstet. 2010;111:115–8.  [PubMed]

17.  Tamil Nadu Health Systems Project. [Last accessed on 2013 March 29]. Available from:http://www.tnhsp.org/screening-cervical-cancer-and-breast-cancer .

18.  Sankaranarayanan R, Wesley RS. Lyon: IARC Press; 2003. A Practical Manual on Visual Screening for Cervical Neoplasia. IARC Technical Publication, 41.

19.  Sellors JW, Sankaranarayanan R. Lyon: IACR; 2003. Colposcopy and treatment of cervical intraepithelial neoplasia: A beginners’ manual.

20.  Visual inspection with acetic acid for cervical cancer screening: Test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Lancet. 1999;353:869–73. [PubMed]

Corresponding Author

Naik Meena MD MRCOG

Assistant Professor, Department of Obstetrics and Gynaecology,

Chandulala Chandrakar Memorial Medical College, Durg, Chhattisgarh